• 제목/요약/키워드: toxin A

검색결과 1,091건 처리시간 0.029초

마우스 및 랫드에서 botulinum toxin type A의 단회 및 28일 반복투여 독성시험 (Single and 28-day repeated dose toxicity studies of botulinum toxin type A in mice and rats)

  • 전태원;김지영;현선희;김남희;이상규;김춘화;우희동;양기혁;정현호;정태천
    • 대한수의학회지
    • /
    • 제43권1호
    • /
    • pp.57-66
    • /
    • 2003
  • Single and 28-day repeated dose toxicity studies of botulimnn toxin type A were carried out in ICR mice and Sprague-Dawley rats, respectively. In the single dose toxicity study, botulinwn toxin was injected intraperitoneally to male and female mice at a single dose of 40, 59, 89 133 and 200 ng/10 ml saline/kg. All animals died from 59 ng/kg group. Some clinical signs, such as decrease in locomotor activity, dyspnea, prone position and ptosis, were observed in most of both sexes from 59 ng/kg group, but no signs were seen in all animals at 40 ng/kg group. The results showed that the median lethal dose of botulinum toxin might be in the range of 40-59 ng/kg in both sexes. In the repeated dose toxicity study, the test material was administered intradermally for 28 days at doses of 0 (vehicle-treated control), 1.25, 2.5, 5.0 and $10.0ng/head/50{\mu}{\ell}$ saline in male and female rats. No test material-related changes were noted in survivals, clinical signs, food and water consumptions and gross finding in any group. Botulinum toxin treatment significantly decreased the body weight gain rate in male of 5.0 ng/head group and over and in female of 10.0 ng/head group compared to vehicle-treated control. One or more relative organ weights (i.e., spleen, thymus, liver and kidney) were increased significantly from 5.0 ng/head group compared to vehicle-treated control in both sexes. Serum biochemistry revealed increases in aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine phosphokinase, total protein and albumin in male, and increases in AST and ALT and decreases in $K^+$ and $Cl^-$ in female without dose-pendent manners. In the histopathological study, physical stimulation by needle caused slight inflammations of dennis. In addition, botulinum toxin treatment induced denervation of nerve cell and disuse of muscle, resulting in atrophy of skeletal muscle in both sexes from 2.5 ng/head group. When the antibodies to toxin were determined in all animals, a significant increase in serum antibodies was observed from 5.0 ng/head group. The results showed that the NOAEL of botulinum toxin might be 1.25 ng/head for 28-day repeated dose toxicity in rats.

Potassium Acetate Blocks Clostridium difficile Toxin A-Induced Microtubule Disassembly by Directly Inhibiting Histone Deacetylase 6, Thereby Ameliorating Inflammatory Responses in the Gut

  • Lu, Li Fang;Kim, Dae Hong;Lee, Ik Hwan;Hong, Ji;Zhang, Peng;Yoon, I Na;Hwang, Jae Sam;Kim, Ho
    • Journal of Microbiology and Biotechnology
    • /
    • 제26권4호
    • /
    • pp.693-699
    • /
    • 2016
  • Clostridium difficile toxin A is known to cause deacetylation of tubulin proteins, which blocks microtubule formation and triggers barrier dysfunction in the gut. Based on our previous finding that the Clostridium difficile toxin A-dependent activation of histone deacetylase 6 (HDAC-6) is responsible for tubulin deacetylation and subsequent microtubule disassembly, we herein examined the possible effect of potassium acetate (PA; whose acetyl group prevents the binding of tubulin to HDAC-6) as a competitive/false substrate. Our results revealed that PA inhibited toxin A-induced deacetylation of tubulin and recovered toxin A-induced microtubule disassembly. In addition, PA treatment significantly decreased the production of IL-6 (a marker of inflamed tissue) in the toxin A-induced mouse enteritis model. An in vitro HDAC assay revealed that PA directly inhibited HDAC-6-mediated tubulin deacetylation, indicating that PA acted as a false substrate for HDAC-6. These results collectively indicate that PA treatment inhibits HDAC-6, thereby reducing the cytotoxicity and inflammatory responses caused by C. difficile toxin A.

C. difficile 톡신이 야기하는 대장상피세포 미세소관 변형에 대한 초산의 억제 효능 (Acetic Acid Recovers Microtubule Disassembly Caused by Clostridium difficile Toxin A in Human Colonocytes through Increased Tubulin Acetylation)

  • 윤이나;김호
    • 생명과학회지
    • /
    • 제28권8호
    • /
    • pp.885-891
    • /
    • 2018
  • 급성위막성대장염(Pseudomembranous colitis)은 C. difficile 세균이 분비하는 톡신A에 의해 유발되는 것으로 알려져 있다. 톡신A에 의한 점막 상피세포의 장벽기능 감소가 발병 원인으로 알려져 있다. 최근 연구에 의하면 톡신 A는 대장상피세포 속 HDAC-6의 활성을 높여 튜블린의 탈아세틸화를 증가시키는 것으로 알려져 있다. 튜블린 단백질의 탈아세틸화는 미세소관 불 형성을 초래하여 점막 상피세포의 극단적인 세포 형태 변형을 야기하게 되며 결국 상피세포의 고유기능인 장벽 기능이 파괴된다고 알려져 있다. 최근 연구자 등은 potassium acetate가 톡신A에 의한 튜블린 탈아세틸화와 미세소관 불 형성을 회복시켜 장염을 유의하게 억제함을 보고하였다. 따라서 본 연구에서는 아세틸기를 포함하는 또 다른 간단한 화학구조의 초산을 적용하여 톡신A의 세포독성을 억제하는지 확인해보고자 하였다. 인간 대장상피세포에서 초산 자극은 튜블린 단백질의 아세틸화를 유의하게 증가시켰다. 또한 초산은 대장상피세포 속 미세소관 형성과정도 강하게 촉진시킴을 확인하였다. 초산은 톡신A에 의한 튜블린 탈아세틸화와 미세소관 불 형성 그리고 세포독성 모두를 유의하게 회복시켰다. 이상의 결과는 초산에 의한 미세소관 형성 촉진이 톡신A에 의해 초래되는 세포골격계 파괴와 그로 인한 세포독성을 억제할 수 있음을 보여준다. 따라서 초산이 톡신A의 작용을 차단하여 위막성대장염 증상을 완화시킬 수 있는 치료제로서 개발 가치가 있음을 보여준다.

근권 길항세균 Pseudomonas fluorescens KR164에 Bacillus thuringiensis HD-1 유전자의 삽입과 발현 (Expression of Bacillus thringiensis HD-1 gene in rhizobacteria Pseudomonas fluorescens KR164)

  • 김영일;이영환;강흔수
    • Applied Biological Chemistry
    • /
    • 제35권4호
    • /
    • pp.227-231
    • /
    • 1992
  • 식물병원성 사상균에 대해 길항력을 갖는 그람음성 Pseudomonas fluorescens KR164의 chromosome에 그람 양성인 Bacillus thuringiensis(BT)의 HD-1 toxin gene을 삽입하기 위하여 이 유전자를 갖는 plasmids pSUPBT과 pSUPBTR을 작성하였다. Conjugation을 이용한 transposition으로 P. fluorescens KR164의 chromosome에 이 plasmids를 삽입시켜 BT toxin 유전자를 갖는 P. fluorescens KR164의 변이균주를 조제하였다. Southern blotting으로 균주의 cellular DNAs를 조사한 결과 모든 변이균주에서 한 개 이상의 BT toxin gene의 삽입이 확인 되었으며 독소단백질의 존재 역시 SDS-PAGE에 의해서 확인되었으며 이러한 독소단백질의 결정 생성은 전자현미경에서도 확인되었다.

  • PDF

Species classification of the toxic dinoflagellate Alexandrium tamarense and A. catenella based on their paralytic shellfish toxin profiles

  • Kim, Young-Soo;Kim, Chang-Hoon
    • 한국양식학회:학술대회논문집
    • /
    • 한국양식학회 2003년도 추계학술발표대회 논문요약집
    • /
    • pp.128-128
    • /
    • 2003
  • The annually outbreak of paralytic shellfish poisoning (PSP) were caused by toxic dinolagellate A. tamarense and A. catenella in Korea. The purpose of this study were to investigate the distribution of PSP-causative organisms, A. tamarense and A. catenella and their species classification. Sediment (Saemangeum, the south open sea) and water samples (southeastern coast) were sampled to establish clonal isolates in 2003. After isolation and purification, strains were cultured under $17^{\circ}C$, f/2 media, 14:10=L:D cycle. PST analysis and species identification were performed by HPLC-FD method and specific DNA probe, respectively. Thirty-ons strains were isolated from the Saemangeum reclamation, southeastern coast including Jinhae Bay and south open sea. PSTs were detected in all cultured strains. In eight strains from south offshore, major toxin components are GTX5, C1/2 and minors are GTX3/4, dcGTX3, neoSTX. Sixteen strains from south coastal area have GTX1/4, neoSTX, C1/2 as major toxin components and GTX2/3 as minors. Seven strains from the Saemangeum reclamation have GTX5, C1/2 as major toxin components and GTX1/2/3/4 as minors. Thus, among eight south offshore isolates, four A. tamarense have more toxic (38.31~l19.16 fmol.$cell^{-1}$) than A. catenella (3.78~13.13 fmol.$cell^{-1}$). With the previous results of different toxin composition, toxin components and toxin contents, .it is toxin profile that could used to diagnosis of regional toxic population and geographical distribution of both A. tamarense and A. catenella and their toxigenic strains.

  • PDF

보툴리눔 독소의 약리 (The Pharmacology of Botulinum Toxin)

  • 이상혁;이현섭;진성민
    • 대한후두음성언어의학회지
    • /
    • 제23권2호
    • /
    • pp.93-98
    • /
    • 2012
  • Botulinum toxins are the most potent toxins known to mankind. Botulinum toxin acts by blocking the cholinergic neuromuscular or the cholinergic autonomic innervation of exocrine glands and smooth muscles. Seven distinct antigenic botulinum toxins (A, B, C, D, E, F and G) produced by different strains of Clostridium botulinum have been described and only A and B type of botulinum toxins were clinically used. Toxins were consisted of a heavy chain with a molecular weight of 100 kD and a light chain with a molecular weight of 50 kD. Toxins are bound with an astounding selectivity to glycoprotein structures located on the cholinergic nerve terminal. Subsequently light chain of toxin is internalized and cleaves different proteins of the acetylcholine transport protein cascade transporting the acetylcholine vesicle from the intracellular space into the synaptic cleft. After a decade of therapeutic application of the toxin, no anaphylaxis or deaths have been reported and systemic adverse effects have not been reported so far. However the toxin's immunologic properties can lead to the stimulation of antibody production, potentially rendering further treatments ineffective. Botulinum toxin is a safe and effective treatment. Use of botulinum toxin in clinical medicine has grown exponentially in recent years, and many parts of the human body are now being targeted for therapeutic purposes.

  • PDF

Simulation Study on the Efficacy of Toxin Removal by Pulsatile Flow in Blood Purification Systems that use Semipermeable Membranes

  • Lim, Ki-Moo;Shim, Eun-Bo
    • 대한기계학회:학술대회논문집
    • /
    • 대한기계학회 2008년도 추계학술대회A
    • /
    • pp.1655-1659
    • /
    • 2008
  • Using numerical models, we investigated the efficiency of toxin removal using pulsatile flow in blood purification systems that use semipermeable membranes. The model consisted of a three-compartmental mass transfer model for the inside body and a solute kinetics model for the dialyzer. The model predicted the toxin concentration inside the body during blood purification therapy, and the toxin removal efficiencies at different flow configurations were compared quantitatively. According to the simulation results, the clearances of urea and ${\beta}_2$ microglobulin (B2M) using a pulsatile pump were improved by up to 30.9% for hemofiltration, with a 2.0% higher urea clearance and 4.6% higher B2M clearance for high flux dialysis, and a 3.9% higher urea clearance and 8.2% higher B2M clearance for hemodiafiltration. These results suggest that using a pulsatile blood pump in blood purification systems with a semipermeable membrane improves the efficacy of toxin removal, especially for large molecules and hemofiltration treatment.

  • PDF

보툴리눔독소를 이용한 후두전적출술후 식도발성장애 및 식도이완불능증의 치료 (Botulinum Toxin Injection for Postlaryngectomy esophageal speech failure and Achalasia)

  • 최홍식;문형진;한재욱;서진원;김광문
    • 대한기관식도과학회지
    • /
    • 제3권2호
    • /
    • pp.302-306
    • /
    • 1997
  • Persistent pharygoesophageal spasm has been demonstrated to be responsible for poor speech rehabilitation after laryngectomy Management of these patients has included bougienage and pharyngeal neurectomy. Achalasia is a disorder of swallowing in which the lower esophageal sphincter fails to relax. Botulinum toxin injection of the upper esophageal sphincter or lower esophageal sphincter has been successfully used diagnostically and therapeutically for esophageal speech failure or achalasia. So, we report the use of botulinum toxin, a paralytic agent, for the treatment of these conditions.

  • PDF

이갈이를 동반한 교근비대증 환자에서 보툴리눔 A형 독소 주사의 효과 경험예 (A case of the effect of botulinum toxin type injection for the masseter hypertro patient with bruxism)

  • 김성택;함종욱;최종훈;김종열
    • 대한치과의사협회지
    • /
    • 제41권6호통권409호
    • /
    • pp.450-454
    • /
    • 2003
  • The Purpose of this study is to report the effect botulinum toxin type A injection for the masseter hypertrophy patient with bruxism. Nine patients enrolled in this study were diagnosed as masseter hypertrophy associated with bruxism and the patients were injected with a 25U of botulinum toxin type A (BTXA:Lanzhou) to each masseter muscles. All nine patients showed marked reduction of masseter hypertrophy and eight patients reported the resolution of bruxism in 8 weeks after injection, with no significant complications. This preliminary study suggest that the botulinum toxin type A injection is an alternative method to treat the masseter hypertrophy with bruxism.

  • PDF

AM-toxin을 이용(利用)한 사과점무늬낙엽병균(Alternaria mali)의 공기중(空氣中) 밀도(密度) 조사(調査) (The Use of AM-toxin in Monitoring the Numbers of Air-borne Spores of Alternaria mali Causing Leaf Spot in Apple Orchards)

  • 유승헌;심형권;박종성
    • 한국응용곤충학회지
    • /
    • 제26권4호
    • /
    • pp.273-275
    • /
    • 1987
  • Changes in the numbers of air-borne spores of Alternaria mali causing the Alternaria leaf spot of apple were investigated in apple orchards, by monitoring their AM- toxin(host-specific toxin) producing ability. Most of the air-borne Alternaria in apple orchards were not AM-toxin producers. In culture, only about 2% of Alternaria isolates from a commercially managed apple orchards produced the toxin that was highly toxic only to susceptible leaves.

  • PDF